Coverage of our peer-reviewed research and news reporting in the healthcare and mainstream press.
An article by The St. Augustine Record referenced a study published in the December 2012 issue of The American Journal of Managed Care® (AJMC®). The study, “Personalized Preventive Care Leads to Significant Reductions in Hospital Utilization,” assessed the impact of the MDVIP personalized preventive care model on hospital utilization and found that MDVIP members' rates were substantially lower than nonmembers'. The study was additionally spotlighted by The Heartland Institute.
Washington Examiner’s piece “Don't 'Fix' Surprise Billing at the Expense of Coronavirus Readiness” featured a study published in the August 2019 issue of AJMC®, “Influence of Out-of-Network Payment Standards on Insurer—Provider Bargaining: California’s Experience.” The study showcased California’s experience in implementing a policy to address surprise medical billing, which subsequently found that out-of-network payment standards can influence payer—provider bargaining leverage, which itself affects prices and network breadth.
The Bulletin cited a study published in the October 2000 issue of AJMC®, “Diagnosis of Skin Disease by Nondermatologists.” In the study findings highlighted in the article, researchers determined that although most visits for skin disease are managed by primary care physicians, these physicians lack effective training in skin disease presentation, making it difficult to accurately diagnose.
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen